🦊/Lists

Biotech Investors & VC Firms in United States

1265 firms in this list, with a median first check of $500K. 278 of them lead rounds. Generated from verified public data and updated continuously.

O2h Ventures
CambridgePre-Seed–Series A
22 people
Taiwan Global Angels
BerkeleyPre-Seed–Growth$300K – $3M
19 people
Ocean Azul Partners
Coral GablesSeed–Series A$500K – $2M
9 people
Side Door Ventures
Fernandina BeachPre-Seed–Growth$300K – $5M
18 people
Transform Capital Management
San FranciscoSeed–Late Stage
15 people
Owl Rock Capital
New YorkGrowth–Late Stage$20M – $250M
20 people
DCVC Bio
Palo AltoSeed–Growth
16 people
Health2047
San FranciscoSeed
22 people
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
15 people
Omega Funds
BostonSeed–Late Stage
21 people
SAV (Scale Asia Ventures)
Palo AltoSeed–Series B
12 people
Oncology Ventures
New YorkSeed–Series B
17 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
14 people
Rhapsody Venture Partners
CambridgePre-Seed–Seed$500K – $2M
10 people
Regeneration.VC
Redondo BeachSeed–Series B$1M – $3M
9 people
Trinity Capital
PhoenixGrowth
18 people
Foresite Labs
San FranciscoPre-Seed
25 people
One Planet Capital
CambridgePre-Seed–Series A$32K – $640K
6 people
Better Ventures Central Llc
OaklandPre-Seed–Growth$500K – $1.5M
4 people
BIOSPRING PARTNERS
New YorkGrowth–Late Stage
22 people
Vensana Capital
MinneapolisSeries A–Late Stage
13 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
21 people
Avalon BioVentures
San DiegoPre-Seed–Series A
17 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.